Is liver damage down the TRAIL for a promising cancer therapy?

September 01, 2006

TRAIL is a protein that is considered a promising cancer therapeutic because it can kill tumor cells and can synergize with conventional chemotherapeutic agents to destroy tumor cells. However, controversy surrounds whether or not TRAIL affects nontumor cells, in particular cells of the liver -- which are known as hepatocytes. Now, Thomas Brunner and colleagues from the University of Bern in Switzerland show that although TRAIL alone does not kill mouse hepatocytes in vitro, it does enhance both in vitro and in vivo hepatocyte cell death induced by signaling through another protein on the surface of hepatocytes known as Fas. This study, which is published in the September issue of the Journal of Clinical Investigation, indicates that TRAIL can enhance hepatocyte cell death, and therefore liver damage, initiated by signaling through Fas. This has important clinical implications because cells that are able to trigger signaling through Fas are present in the liver, especially during inflammation, making liver damage a potential risk of TRAIL-based therapeutics.
TITLE: TRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality


Thomas Brunner

University of Bern, Bern, Switzerland.

Phone: 41-31-632-49-71; Fax: 41-31-381-87-64


View the PDF of this article at:

JCI Journals

Related Protein Articles from Brightsurf:

The protein dress of a neuron
New method marks proteins and reveals the receptors in which neurons are dressed

Memory protein
When UC Santa Barbara materials scientist Omar Saleh and graduate student Ian Morgan sought to understand the mechanical behaviors of disordered proteins in the lab, they expected that after being stretched, one particular model protein would snap back instantaneously, like a rubber band.

Diets high in protein, particularly plant protein, linked to lower risk of death
Diets high in protein, particularly plant protein, are associated with a lower risk of death from any cause, finds an analysis of the latest evidence published by The BMJ today.

A new understanding of protein movement
A team of UD engineers has uncovered the role of surface diffusion in protein transport, which could aid biopharmaceutical processing.

A new biotinylation enzyme for analyzing protein-protein interactions
Proteins play roles by interacting with various other proteins. Therefore, interaction analysis is an indispensable technique for studying the function of proteins.

Substituting the next-best protein
Children born with Duchenne muscular dystrophy have a mutation in the X-chromosome gene that would normally code for dystrophin, a protein that provides structural integrity to skeletal muscles.

A direct protein-to-protein binding couples cell survival to cell proliferation
The regulators of apoptosis watch over cell replication and the decision to enter the cell cycle.

A protein that controls inflammation
A study by the research team of Prof. Geert van Loo (VIB-UGent Center for Inflammation Research) has unraveled a critical molecular mechanism behind autoimmune and inflammatory diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Resurrecting ancient protein partners reveals origin of protein regulation
After reconstructing the ancient forms of two cellular proteins, scientists discovered the earliest known instance of a complex form of protein regulation.

Sensing protein wellbeing
The folding state of the proteins in live cells often reflect the cell's general health.

Read More: Protein News and Protein Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to